Search

Postbiotic Active Component Identification Service

Creative Biolabs provides postbiotic active component identification services to help you determine which molecules in your preparation drive biological activity. We isolate and characterize key fractions such as lipoteichoic acids (LTA), exopolysaccharides (EPS), and surface-associated proteins, then evaluate their effects in vitro using cytokine profiling, TEER barrier assays, and PRR pathway readouts. The result is a clear component-activity map and candidate QC indicators that support mechanism studies, product definition, and downstream quality control.

Why Identifying Postbiotic Active Components Matters

⚠

Unclear Bioactive Molecules

Without identifying the specific active molecules in a postbiotic preparation, it is difficult to determine which fractions are responsible for immune modulation, barrier support, or receptor activation.

⚠

Weak Mechanistic Support

Mechanism claims are difficult to substantiate without linking defined fractions to biological pathways such as TLR2/PRR signaling and downstream cytokine responses.

⚠

Insufficient Product Definition and QC Markers

A postbiotic product cannot be robustly defined or controlled unless measurable structural or functional markers are established for batch consistency and release testing.

According to a consensus statement on postbiotics, the definition of a postbiotic requires a defined preparation of inanimate microorganisms or their components that confers a health benefit on the host. Structural and functional characterization of active components is therefore foundational—not optional—for credible postbiotic development.

Postbiotic Active Component Identification: Service Modules

From isolation through functional validation, our service generates the component-level evidence your postbiotic program needs.

Active Fraction Isolation and Purification

LTA is a major cell-wall glycolipid of gram-positive bacteria and a well-established TLR2 ligand. EPS fractions from postbiotic organisms influence mucoadhesion and immune tone. Surface-associated proteins—including S-layer proteins and other surface-associated proteins—may contribute to epithelial interaction and immunomodulatory responses in postbiotic preparations. We extract and purify each component class from target postbiotic organisms using validated isolation protocols, with purity confirmed by protein, nucleic acid, and endotoxin screening before downstream studies proceed. Yield data and fraction-specific purity documentation are included in all deliverables.

Structural Characterization of LTA, EPS, and Surface Proteins

Structural identity is established for each purified fraction before functional testing. For LTA, this includes NMR and mass spectrometry to confirm backbone identity, D-alanylation status, and glycosyl substituents. EPS fractions are characterized for monosaccharide composition (GC-MS or HPAEC-PAD), molecular weight distribution (SEC-MALS), and linkage patterns. Surface protein fractions are profiled by SDS-PAGE and identified by LC-MS/MS, with candidates annotated against functional databases. Where sub-fractions with distinct structural features are detected, these are flagged for activity-assignment experiments.

In Vitro Functional Assessment

Each purified component fraction undergoes targeted functional profiling using cell-based assays calibrated to postbiotic-relevant endpoints. Preparations are subjected to predefined purity assessment criteria before entering downstream functional studies.

Assay Module Representative Readouts Typical Relevant Fractions
Immune response profiling TNF-α, IL-6, IL-10, IL-12 in macrophage or PBMC models LTA, EPS, surface proteins
Epithelial barrier assessment TEER in Caco-2 or T84 monolayers EPS, surface proteins, selected LTA fractions
PRR pathway analysis TLR2/NF-κB reporter activity, MyD88-related signaling LTA, selected EPS fractions
Inflammatory modulation analysis Cytokine ratio changes, NF-κB modulation relative to stimulated controls LTA structural variants, EPS fractions
Epithelial interaction-related testing Binding or competitive interaction readouts in epithelial models Surface proteins, EPS

Component-Activity Mapping

Structural and functional data generated in parallel are integrated into a component-activity relationship (CAR) summary. This maps each characterized fraction to its functional profile across all tested endpoints, identifies structurally distinct sub-fractions with differential activity, and provides a ranked overview of which components show the strongest and most consistent biological signals. The CAR summary serves as a decision-support tool for lead fraction selection, mechanism-driven product positioning, and partner or regulatory discussions.

Candidate QC Marker Identification

Based on structural characterization and functional testing results, we propose candidate QC markers for each active fraction. Structural markers may include specific glycosyl composition ratios, characteristic NMR signals, or SDS-PAGE band identity. Functional markers may include cytokine induction levels or TEER response at defined dose ranges. These candidates form the basis for future batch release specifications, enabling more robust product definition and a stronger foundation for QC development and partner discussions.

Deliverables: What You Get from Our Postbiotic Component Identification Service

1

Purified Fractions

Characterized LTA, EPS, and surface protein preparations with purity documentation and yield data.

2

Structural Characterization Report

NMR, MS, and composition data with interpretation for each major fraction, including structural annotations.

3

Functional Assay Dataset

Quantitative cytokine, TEER, and PRR reporter results at dose-response range for each purified component.

4

Component-Activity Relationship Summary

Integrated table linking each fraction to observed functional outcomes, ranked by signal strength and consistency.

5

Candidate QC Indicator Proposals

Recommended structural and functional markers for batch release or incoming material testing, with proposed threshold values.

6

Full Technical Report

Consolidated documentation in a format suitable for internal dossiers, partner due diligence, or regulatory submission support.

How the Postbiotic Active Component Identification Service Works

A structured, milestone-based process ensures that structural characterization informs functional testing design before final integration and reporting.

1

Sample Review and Project Scoping

Review organism type, available starting material, target components, and intended functional endpoints to define a feasible and efficient study plan.

2

Component Isolation

Extract and purify LTA, EPS, and surface protein fractions using validated protocols. Purity, yield, and contaminant screening confirmed at this stage.

3

Structural Analysis

Confirm structure via NMR, MS, composition assays, and PAGE. Identify structural variants and sub-fractions of interest for downstream testing.

4

In Vitro Functional Testing

Run cytokine, TEER, and PRR assay panels per agreed endpoint selection. Dose-response experiments capture activity thresholds for each component.

5

Data Integration & Reporting

Combine structural and functional datasets into a component-activity map. Propose candidate QC markers. Deliver full technical report and data package.

Why Choose Creative Biolabs for Postbiotic Component Identification

Faster Decisions on Lead Fractions

Structural characterization and functional testing are run within a single integrated platform—no outsourcing, no data handoff gaps—so you get a clear component-activity picture faster and can prioritize lead fractions with confidence.

Stronger Mechanistic Product Positioning

Assay panels are selected for TLR2/PRR signaling, epithelial barrier function, and cytokine balance—endpoints directly relevant to postbiotic mechanism claims—giving you the biological evidence needed for mechanism-driven product definition and partner positioning.

Solid Basis for QC Development and Partner Reviews

Deliverables are structured around downstream use: candidate QC markers come with proposed measurable thresholds that provide a concrete starting point for batch release development, due diligence discussions, and regulatory dossier preparation.

Modular Scope Matched to Your Program Stage

Whether you are screening multiple fractions early in development or validating a single priority component, the service scope adapts to your program. We cover gram-positive organisms including Lactobacillus, Bifidobacterium, and other postbiotic strains, with single-component or full-panel options available.

Published Data: LTA Structure and Anti-Inflammatory Activity

Peer-reviewed research demonstrates how structural features of purified LTA directly govern its immunomodulatory activity—supporting the core rationale of our identification service.

A 2022 study by Lu et al. published in Foods (MDPI) investigated LTA isolated and purified from several Lactobacillus strains, characterizing the structural composition of each fraction and evaluating their anti-inflammatory properties in LPS-stimulated macrophage models. The study found that purified LTA from different strains exhibited distinct structural profiles and differing capacities to suppress pro-inflammatory cytokines (TNF-α and IL-6) while modulating IL-10 output. These differential effects were observed at defined dose ranges and correlated with the molecular features of each LTA preparation.1

Crucially, cytotoxicity was assessed alongside cytokine measurements, confirming that the immunomodulatory signal was not a consequence of cell death—a methodological control directly relevant to valid postbiotic bioassay design.1

These findings underscore why isolating and structurally characterizing LTA fractions—rather than relying on crude postbiotic extracts—is essential for generating interpretable, reproducible functional data. Our Postbiotic Active Component Identification Service applies this same principle: purification first, characterization second, functional testing third.

Effects of purified LTA on cell viability and the expression of TNF-alpha, IL-10, and IL-6 in LPS-stimulated RAW264.7 cells. (Creative Biolabs Authorized)

Fig.1 Effects of LTA on cytotoxicity and cytokines TNF-α, IL-10, and IL-6 expression in LPS-stimulated RAW264.7 cells.1,3

Frequently Asked Questions

We accept bacterial biomass (wet or lyophilized), culture supernatants, or crude postbiotic preparations as starting material, depending on the component scope requested. Minimum quantities vary by component: LTA and surface protein isolation generally require gram-scale biomass, while EPS isolation from culture supernatants depends on production yield per strain. During project scoping, we will confirm material requirements and provide shipping guidance if client material is being sent to our facility. We can also work from reference strains if no proprietary organism is involved.

LTA preparations are screened for protein contamination (BCA assay), nucleic acid content (UV spectrophotometry), and lipopolysaccharide (LPS) using a chromogenic LAL assay prior to any cell-based experiment. This is critical because residual LPS can dominate immunological readouts in macrophage and PBMC models, masking or confounding the LTA signal. Preparations are subjected to predefined purity assessment criteria before entering downstream functional studies. Purity data are included in the final report.

The service is fully modular. Clients with a specific hypothesis—for example, that LTA is the primary active fraction—can commission LTA isolation, structural characterization, and functional testing alone. Others at an earlier stage may benefit from a broader fractionation approach covering LTA, EPS, and surface proteins in parallel. We discuss program stage and scientific rationale during scoping and recommend an appropriate scope accordingly.

Our core panel includes: immune cytokine profiling (TNF-α, IL-6, IL-10, IL-12 in macrophage and/or PBMC models), TEER measurement in epithelial monolayer models (Caco-2, T84), and PRR pathway reporter assays (TLR2/NF-κB). These endpoints correspond to the most commonly substantiated postbiotic health-benefit categories. Additional assays can be added based on program-specific claims. All assays include positive and negative controls, and dose-response data are generated to define effective concentration ranges.

The component-activity relationship data generated in this service supports proposal of candidate specification markers—both structural and functional. We present these as candidate thresholds based on the current dataset. Translating them into formal batch release specifications requires additional analytical method validation work, which we can also support as a follow-on service engagement.

Other Resources

Creative Biolabs' Live Biotherapeutics - Brochure (Creative Biolabs Original)

Creative Biolabs' Live Biotherapeutics - Brochure

Probiotic Strain Products for NGP Research - Brochure (Creative Biolabs Original)

Probiotic Strain Products for NGP Research - Brochure

Custom Small-scale Probiotic Production - Brochure (Creative Biolabs Original)

Custom Small-scale Probiotic Production - Brochure

Live Biotherapeutics - Creative Biolabs - Video (Creative Biolabs Original)

Live Biotherapeutics - Creative Biolabs - Video

References

  1. Lu, Qianqian, et al. "Structure and anti-inflammation potential of lipoteichoic acids isolated from Lactobacillus strains." Foods 11.11 (2022): 1610. https://doi.org/10.3390/foods11111610
  2. Salminen, Seppo, et al. "The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics." Nature reviews Gastroenterology & hepatology 18.9 (2021): 649-667. https://doi.org/10.1038/s41575-021-00440-6
  3. Distributed under Open Access license CC BY 4.0, without modification.
Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Creative Biolabs-Live Biotherapeutics


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us
Solutions

Copyright © 2026 Creative Biolabs. All Rights Reserved.

Inquiry Basket